PURE BIOTHROID-B No1 tablets pose a serious risk to your health and should not be taken.
The Therapeutic Goods Administration (TGA) has tested a product labelled PURE BIOTHROID-B No1 and found that:
- The tablets contained the presence of bovine thyroid from an undisclosed source that presents a viral safety concern.
The supply of products containing undisclosed ingredients is illegal.
PURE BIOTHROID-B No1 tablets have not been assessed by the TGA for quality, safety or efficacy as required under Australian legislation, and the place of manufacture is not approved by the TGA.
Information for consumers
- Stop taking PURE BIOTHROID-B No1 tablets and take any remaining capsules to your local pharmacy for .
- If you have any concerns arising from your use of this product, consult your health care practitioner.
Action the TGA is taking
The TGA is working with the Australian Border Force (ABF) to help stop future shipments of PURE BIOTHROID-B No1 tablets from entering Australia.
If these capsules are found at the border by the ABF they will be seized and destroyed.
The TGA is advising consumers to exercise extreme caution when and has produced a on the risks associated with buying medicines and medical devices online. Products purchased over the Internet:
- may contain undisclosed and potentially harmful ingredients
- may not meet the same standards of quality, safety and efficacy as those approved by the TGA for supply in Australia.
